Start Testing with MyRisk
Fill in your information below and we’ll send you an email with more information
Every patient has a risk of developing cancer
Knowing your patients’ hereditary cancer risk can dramatically impact the medical management decisions you make today.
1 in 4 patients1 meet criteria for hereditary cancer testing
MyRisk results, whether negative, positive or elevated, can be used to your patients’ benefit. Combined with their cancer family history, the report will provide you with valuable information to effectively make decisions and manage patient cancer risk on an individual basis.
1DeFrancesco et al. Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting. Obstetrics & Gynecology 2018 – published online before print October 10, 2018.
Give your patients a complete answer
When it comes to assessing breast cancer risk, MyRisk goes a step further by giving patients who receive a negative test result a RiskScore®.
What’s RiskScore?
RiskScore is a component of the MyRisk test that provides a personalized estimate of a person’s likelihood to develop breast cancer over the next 5 years and their lifetime, guiding patients and providers to make more confident and informed medical decisions for managing breast cancer risk.
For patients of all ancestries
As the only hereditary cancer test designed for patients of all ancestries, MyRisk with RiskScore helps you give more patients answers about their cancer risks than ever before.
More direction for more patients
56%2 of patients tested with MyRisk qualify for a change in their medical management vs. approximately 10% expected if tested with other labs.
2Myriad Internal Data based on OBGYN and Primary Care Settings, Sept 2019
A partner to your practice
Integrating MyRisk into your practice has never been easier with second-to-none expert support and the MyRisk Management Tool that simplifies reading and implementing results.